Cargando…

An integrated proteomics approach shows synaptic plasticity changes in an APP/PS1 Alzheimer's mouse model

The aim of this study was to elucidate the molecular signature of Alzheimer's disease-associated amyloid pathology. We used the double APP(swe)/PS1(ΔE9) mouse, a widely used model of cerebral amyloidosis, to compare changes in proteome, including global phosphorylation and sialylated N-linked g...

Descripción completa

Detalles Bibliográficos
Autores principales: Kempf, Stefan J., Metaxas, Athanasios, Ibáñez-Vea, María, Darvesh, Sultan, Finsen, Bente, Larsen, Martin R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085108/
https://www.ncbi.nlm.nih.gov/pubmed/27144524
http://dx.doi.org/10.18632/oncotarget.9092
_version_ 1782463504618356736
author Kempf, Stefan J.
Metaxas, Athanasios
Ibáñez-Vea, María
Darvesh, Sultan
Finsen, Bente
Larsen, Martin R.
author_facet Kempf, Stefan J.
Metaxas, Athanasios
Ibáñez-Vea, María
Darvesh, Sultan
Finsen, Bente
Larsen, Martin R.
author_sort Kempf, Stefan J.
collection PubMed
description The aim of this study was to elucidate the molecular signature of Alzheimer's disease-associated amyloid pathology. We used the double APP(swe)/PS1(ΔE9) mouse, a widely used model of cerebral amyloidosis, to compare changes in proteome, including global phosphorylation and sialylated N-linked glycosylation patterns, pathway-focused transcriptome and neurological disease-associated miRNAome with age-matched controls in neocortex, hippocampus, olfactory bulb and brainstem. We report that signalling pathways related to synaptic functions associated with dendritic spine morphology, neurite outgrowth, long-term potentiation, CREB signalling and cytoskeletal dynamics were altered in 12 month old APP(swe)/PS1(ΔE9) mice, particularly in the neocortex and olfactory bulb. This was associated with cerebral amyloidosis as well as formation of argyrophilic tangle-like structures and microglial clustering in all brain regions, except for brainstem. These responses may be epigenetically modulated by the interaction with a number of miRNAs regulating spine restructuring, Aβ expression and neuroinflammation. We suggest that these changes could be associated with development of cognitive dysfunction in early disease states in patients with Alzheimer's disease.
format Online
Article
Text
id pubmed-5085108
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-50851082016-10-31 An integrated proteomics approach shows synaptic plasticity changes in an APP/PS1 Alzheimer's mouse model Kempf, Stefan J. Metaxas, Athanasios Ibáñez-Vea, María Darvesh, Sultan Finsen, Bente Larsen, Martin R. Oncotarget Research Paper: Pathology The aim of this study was to elucidate the molecular signature of Alzheimer's disease-associated amyloid pathology. We used the double APP(swe)/PS1(ΔE9) mouse, a widely used model of cerebral amyloidosis, to compare changes in proteome, including global phosphorylation and sialylated N-linked glycosylation patterns, pathway-focused transcriptome and neurological disease-associated miRNAome with age-matched controls in neocortex, hippocampus, olfactory bulb and brainstem. We report that signalling pathways related to synaptic functions associated with dendritic spine morphology, neurite outgrowth, long-term potentiation, CREB signalling and cytoskeletal dynamics were altered in 12 month old APP(swe)/PS1(ΔE9) mice, particularly in the neocortex and olfactory bulb. This was associated with cerebral amyloidosis as well as formation of argyrophilic tangle-like structures and microglial clustering in all brain regions, except for brainstem. These responses may be epigenetically modulated by the interaction with a number of miRNAs regulating spine restructuring, Aβ expression and neuroinflammation. We suggest that these changes could be associated with development of cognitive dysfunction in early disease states in patients with Alzheimer's disease. Impact Journals LLC 2016-04-28 /pmc/articles/PMC5085108/ /pubmed/27144524 http://dx.doi.org/10.18632/oncotarget.9092 Text en Copyright: © 2016 Kempf et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper: Pathology
Kempf, Stefan J.
Metaxas, Athanasios
Ibáñez-Vea, María
Darvesh, Sultan
Finsen, Bente
Larsen, Martin R.
An integrated proteomics approach shows synaptic plasticity changes in an APP/PS1 Alzheimer's mouse model
title An integrated proteomics approach shows synaptic plasticity changes in an APP/PS1 Alzheimer's mouse model
title_full An integrated proteomics approach shows synaptic plasticity changes in an APP/PS1 Alzheimer's mouse model
title_fullStr An integrated proteomics approach shows synaptic plasticity changes in an APP/PS1 Alzheimer's mouse model
title_full_unstemmed An integrated proteomics approach shows synaptic plasticity changes in an APP/PS1 Alzheimer's mouse model
title_short An integrated proteomics approach shows synaptic plasticity changes in an APP/PS1 Alzheimer's mouse model
title_sort integrated proteomics approach shows synaptic plasticity changes in an app/ps1 alzheimer's mouse model
topic Research Paper: Pathology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085108/
https://www.ncbi.nlm.nih.gov/pubmed/27144524
http://dx.doi.org/10.18632/oncotarget.9092
work_keys_str_mv AT kempfstefanj anintegratedproteomicsapproachshowssynapticplasticitychangesinanappps1alzheimersmousemodel
AT metaxasathanasios anintegratedproteomicsapproachshowssynapticplasticitychangesinanappps1alzheimersmousemodel
AT ibanezveamaria anintegratedproteomicsapproachshowssynapticplasticitychangesinanappps1alzheimersmousemodel
AT darveshsultan anintegratedproteomicsapproachshowssynapticplasticitychangesinanappps1alzheimersmousemodel
AT finsenbente anintegratedproteomicsapproachshowssynapticplasticitychangesinanappps1alzheimersmousemodel
AT larsenmartinr anintegratedproteomicsapproachshowssynapticplasticitychangesinanappps1alzheimersmousemodel
AT kempfstefanj integratedproteomicsapproachshowssynapticplasticitychangesinanappps1alzheimersmousemodel
AT metaxasathanasios integratedproteomicsapproachshowssynapticplasticitychangesinanappps1alzheimersmousemodel
AT ibanezveamaria integratedproteomicsapproachshowssynapticplasticitychangesinanappps1alzheimersmousemodel
AT darveshsultan integratedproteomicsapproachshowssynapticplasticitychangesinanappps1alzheimersmousemodel
AT finsenbente integratedproteomicsapproachshowssynapticplasticitychangesinanappps1alzheimersmousemodel
AT larsenmartinr integratedproteomicsapproachshowssynapticplasticitychangesinanappps1alzheimersmousemodel